Released: June 1, 2022
Recorded: May 27, 2022
Expiration Date: June 1, 2025
About This Webinar
Ever since its FDA approval in 2014, the brain-responsive
neurostimulation (RNS) device has not just expanded the spectrum of
available treatments for refractory epilepsy, but also provided new
research avenues based on an ever-expanding database of chronic, ambulatory electrocorticography
(ECog) data recorded by the RNS devices. In this 1-hour live webinar
we will have an expert in RNS treatment and research provide you
with clinical and management insights for epilepsy care derived from
ambulatory ECog-data recorded by the RNS device followed by a moderated
audience discussion on the topic.
Presenter
Dr. Vikram Rao, MD, PhD
University of California, San Francisco
Learning Objectives:
At the end of this webinar, attendees should be able to:
- Discuss how ambulatory ECog-data captured by the brain-responsive neurostimulation (RNS) device can inform medical, neuromodulatory and surgical management of epilepsy
- Describe how ambulatory ECog-data captured by the brain-responsive neurostimulation (RNS) device can reveal natural seizure patterns and contribute to seizure prediction
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company. Unless otherwise indicated (*), none of the planners or faculty of this activity have any financial relationships to disclose. All relevant financial relationships with ineligible companies have been mitigated. The following individuals contributed to this activity’s content.
Planning Committee* and Faculty
Vikram Rao-Consultant: Neuropace
*David Ficker, MD-Consultant: Greenwich Pharmaceutical, Best Doctors, Verana Health
*Madison Berl, PhD
*Jeannine Conway, PharmD-Consultant: Greenwich Biosciences
*Tyler Gaston, MD-Consultant: Greenwich Biosciences, Inc.
*Soundarya N. Gowda, MD
*Nicole Hartmann, DO, MBS
*Elaine Kiriakopoulos, MD, MSc
*Liu Lynn, MD
*Wolfgang Muhlhofer, MD
*Madona Plueger, ACNS-BC, APRN, CNRN, FAES
*Olga Selioutski, DO
*Jaysingh Singh, MD
*Chengyuan Wu, MD
CME Reviewer
Ika Noviawaty, MD
American Epilepsy Society Staff Planners
Cristina Graham
Kandice Kidd, MA
Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. In accordance with the ACCME Standards for Commercial Support of CME, the AES implemented the mechanisms of prospective peer review of this CME activity, to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence.
Accreditation
The American Epilepsy Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
For more information regarding contact hours, please call American Epilepsy Society 312.883.3800 or education@aesnet.org.
Credit Designation
The American Epilepsy Society designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Certificate
To receive credit for your participation in this activity, please complete the evaluation survey provided at the conclusion of the activity.
Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.
Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.